Wuxi sees Q1 revenues boosted again by manufacturing services
China-based Wuxi announced 11% growth in its net revenues when compared to last year, which was boosted by manufacturing services the most of all service offerings.
China-based Wuxi announced 11% growth in its net revenues when compared to last year, which was boosted by manufacturing services the most of all service offerings.
A European project has developed a low cost and rapid, on-the-spot solution for cleaning verification in pharmaceutical facilities.
Crown Biosciences has partnered with China’s biggest producer of mutant mice to build better experimental models for its cancer research sponsors, as part of its $26.5m (£16m) venture funding.
In an industry first, bioanalytical CRO Tandem Labs has announced the availability of biomarker assays for human clinical studies using the Meso Scale Discovery V-PLEX biomarker platform, which have been already validated by Tandem in human serum.
Despite a nearly $15bn increase in its offer, AstraZeneca has once again rejected Pfizer’s attempt to take over its British rival.